|
Experience of implementing a novel random sampling BICR audit for investigator (INV)-assessed progression-free survival (PFS) in the PALOMA-3 trial. |
|
|
Employment - Pfizer; Pfizer (I) |
Stock and Other Ownership Interests - Pfizer; Pfizer (I) |
|
|
Employment - Janssen; Pfizer |
Stock and Other Ownership Interests - Pfizer |
Research Funding - Pfizer |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Pfizer |
|
|
|
Stock and Other Ownership Interests - Pfizer |
Travel, Accommodations, Expenses - Pfizer |
|
|
Honoraria - Agendia; Celgene; Dompé Farmaceutici; Pfizer |
Consulting or Advisory Role - Cynvenio Biosystems; Dompé Farmaceutici; Newomics; Vortex Biosciences |